AG
MDCO

Advisor Group’s Medicines Co MDCO Stock Holding History

Advisor Group’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$78K Sell
917
-675
-42% -$45K ﹤0.01% 3121
2019
Q3 		$79K Buy
1,592
+497
+45% +$19.8K ﹤0.01% 3074
2019
Q2 		$39K Buy
1,095
+7
+0.6% +$229 ﹤0.01% 3549
2019
Q1 		$30K Sell
1,088
-65
-6% -$1.53K ﹤0.01% 3744
2018
Q4 		$21K Sell
1,153
-62
-5% -$1.44K ﹤0.01% 3793
2018
Q3 		$36K Buy
1,215
+226
+23% +$8.52K ﹤0.01% 3528
2018
Q2 		$36K Sell
989
-166
-14% -$5.39K ﹤0.01% 3365
2018
Q1 		$38K Sell
1,155
-76
-6% -$2.38K ﹤0.01% 3284
2017
Q4 		$35K Buy
1,231
+177
+17% +$5.45K ﹤0.01% 3343
2017
Q3 		$39K Buy
1,054
+29
+3% +$1.07K ﹤0.01% 3128
2017
Q2 		$39K Sell
1,025
-75
-7% -$3.34K ﹤0.01% 3018
2017
Q1 		$54K Sell
1,100
-80
-7% -$3.65K ﹤0.01% 2649
2016
Q4 		$40K Sell
1,180
-152
-11% -$5.39K ﹤0.01% 2780
2016
Q3 		$51K Buy
1,332
+52
+4% +$1.96K ﹤0.01% 2540
2016
Q2 		$41K Buy
+1,280
New +$45.1K ﹤0.01% 2582

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Advisor Group's MDCO Position: Q4 2019 in Review

Advisor Group reduced its Medicines Co (MDCO) stake by 42% in Q4 2019, selling an estimated $45K and leaving 917 shares worth $78K. The position accounts for ﹤0.01% of the portfolio, ranked #3121.

Advisor Group first reported a position in MDCO in Q2 2016 and has held it in 15 quarters since. The position peaked at $79K in Q3 2019. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

  • Advisor Group held 917 shares of Medicines Co worth $78K as of Q4 2019.
  • Advisor Group sold 675 Medicines Co shares in Q4 2019, an estimated $45K.
  • Medicines Co made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3121 holding.
  • Advisor Group first reported a position in Medicines Co in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Medicines Co position peaked at $79K in Q3 2019.
  • 284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.